medline.ch Urologie-Nephrologie Tumoren BPH

	Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group. BMC Cancer Fernández-Díaz N, Mateos-González M, Pertejo-Fernández A, Cacho-Lavín JD, Juan-Fita MJ, Chirivella-González I, Arruti-Ibarbia M, Fernández-Calvo O, Fernández-Núñez N, Méndez-Vidal MJ, Lázaro-Quintela M, Molina-Díaz A, Del Pozo-Alonso N, Etxaniz-Ulazia O, García-Acuña SM, Betancor YZ, Azueta-Etxebarria A, Calatrava-Fons A, Lombardía-Rodríguez H, Alarcón-Molero L, Etxegarai-Ganboa L, Antón-Cameselle A, Bello-Giz JA, Neira-De Paz CM, Cabaleiro T, González-Serrano T, Ortiz-Rey JA, Sacristán-Lista F, García-Rubín S, Ortega E, Carrato-Moñino C, Aguín-Losada S, León-Mateos L, García-González J, Pinto-Marín Á, Duran I, López-López R, Anido-Herranz U, Ruiz-Bañobre J. PMID: 41316036 [PubMed - indexed for MEDLINE]
	Ultrasensitive electrochemical biosensor based on MXene quantum dots for prostate cancer biomarker detection. Sci Rep Safarpoor M, Asfaram A, Ghaedi M, Dinarvand R. PMID: 41315352 [PubMed - indexed for MEDLINE]
	Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol Perimbeti S, Jamroze A, Gopalakrishnan D, Jain R, Jiang C, Holleran JL, Parise RA, Bies R, Quinn D, Attwood K, Liu X, Green K, Kirk JS, Beumer JH, Tang DG, Chatta G. PMID: 41315064 [PubMed - indexed for MEDLINE]
	Low-dose abiraterone acetate for the treatment of prostate cancer: An observational cohort study. Farm Hosp Di-Giuseppe LA, Ramirez-Murillo RA, Aymar MD, Basbus LR, Cornec M, Terrasa SA, Posadas-Martínez ML, Burgos MA, Buela G, Cayol F. PMID: 41314925 [PubMed - as supplied by publisher]
	Bladder EpiCheck triggered Photodynamic Diagnosis biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol Mariappan P, Hart-Brooke J, Sparks R, Lord-McKenzie T. PMID: 41314886 [PubMed - as supplied by publisher]
	Assessing risk stratification in Bacillus Calmette-GuÃ©rin-treated high-grade Ta nonmuscle-invasive bladder cancer patients. Urol Oncol Finocchiaro A, Contieri R, Piccolini A, Brin P, Moretto S, Dagnino F, Aljoulani M, Uleri A, Avolio P, Beatrici E, Mancon S, Paciotti M, Fasulo V, Saita A, Casale P, Lughezzani G, Buffi N, Lazzeri M, Hurle R. PMID: 41314879 [PubMed - as supplied by publisher]
	Comparison of spinal versus general anaesthesia in high-risk non-muscle invasive bladder cancer: study protocol for a randomised controlled trial. BMJ Open Fang CW, Shau WY, Fan SZ, Chueh JS. PMID: 41314851 [PubMed - indexed for MEDLINE]
	Spatial patterns of testicular cancer diagnosis in Australia, 2010-2019. Spat Spatiotemporal Epidemiol Bainomugisa CK, Dasgupta P, Cameron JK, Tran B, Cramb SM, Baade PD. PMID: 41314725 [PubMed - indexed for MEDLINE]
	Primary endpoint analysis of the phase II DESTINATION-MRL trial for patients with intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys Dassen MG, Tree AC, Wiersema L, Neijndorff B, de Ruiter P, van der Linden J, Mitchell A, Dunlop A, Alexander S, Breitkreutz DY, Cooper S, Janssen T, Pos F, Vesprini D, van der Heide UA. PMID: 41314554 [PubMed - as supplied by publisher]
	Comparison of the therapeutic potential of exosomes derived from different cells for the treatment of prostate cancer. Crit Rev Oncol Hematol Mehr FK, Emtiazi N, Zolfi E, Moradi Y. PMID: 41314483 [PubMed - as supplied by publisher]
	Exploration of oxidative stress-related molecular signature for clear cell renal cell carcinoma. Discov Oncol Jin Z, Hu B, Zhu S, Fu S, Deng Z, Wang C, Liu J, Wang T, Wu Y. PMID: 41313400 [PubMed]
	From macroscopic clearance to molecular eradication: paradigm shift and future perspectives in the detecting of residual lesions after transurethral resection of bladder tumors. Expert Rev Anticancer Ther Zhang Y, Yan R, Wang H, Man J, Yang L. PMID: 41313232 [PubMed - as supplied by publisher]
	Comparing [18F]-PSMA-1007, [18F]-choline positron emission tomography, computerized tomography and bone scintigraphy in prostate cancer recurrence. Medicina (B Aires) Bergero MA, Modina P, Arceluz M, Rios L, Costa L, David C, Faccio F. PMID: 41313098 [PubMed - indexed for MEDLINE]
	A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases. Future Oncol Tombal B, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Briers E, Lagström M, Coens C, Poncet C, Fournier B, Gillessen S. PMID: 41313045 [PubMed - as supplied by publisher]
	EXPRESS: HCAR2 inhibits prostate cancer invasion and metastasis by regulating cAMP signaling pathway. J Investig Med Li Y, Chen H, Huang R. PMID: 41312963 [PubMed - as supplied by publisher]
	Association of IL-1Î² Gene Polymorphism with Prostate Cancer Severity, Prostate Volume, and PSA Levels: A Case-Control Study. Asian Pac J Cancer Prev Ismael AA, Hussein AM, Saber AA. PMID: 41312941 [PubMed - indexed for MEDLINE]
	Nonâ€‘coding RNAs in epithelialâ€‘mesenchymal transition of renal cell carcinoma (Review). Mol Med Rep Liu Z, Zhou H, Shen J, Qi Y, Gong X, Zhang C. PMID: 41312723 [PubMed - indexed for MEDLINE]
	LLM-BCgrading: Large language model-based Chinese medical long text classification for bladder cancer grade prediction. Digit Health Pan X, Wen L, Li Y, Zhang Y, Lu M. PMID: 41312143 [PubMed]
	Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5â€‰T MR Guided Adaptive Technique. Prostate Romei A, Orsatti C, Allegra AG, Nicosia L, Pastorello E, Ricchetti F, Giaj-Levra N, De-Colle C, Rigo M, Ruggieri R, Alongi F. PMID: 41311355 [PubMed - as supplied by publisher]
	Integrative multi-omics and single-cell transcriptomics reveal ARHGEF12 driving chemoresistance in bladder cancer. Hereditas Zhu K, Zhang Z, Li T, Sun Y, Zhu J, Wu L, Zhang X, Tong H, Qin Z, Wang A, He W. PMID: 41310897 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 183683

Seite 1 von 9185



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung